JPS5089335A - - Google Patents
Info
- Publication number
- JPS5089335A JPS5089335A JP49095466A JP9546674A JPS5089335A JP S5089335 A JPS5089335 A JP S5089335A JP 49095466 A JP49095466 A JP 49095466A JP 9546674 A JP9546674 A JP 9546674A JP S5089335 A JPS5089335 A JP S5089335A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7314010A FR2199675A5 (enExample) | 1972-04-17 | 1973-04-17 | |
| FR7344344A FR2327230A2 (fr) | 1973-12-12 | 1973-12-12 | Procede de preparation de derives de la methyl-1 (m-trifluoromethyl-phenyl)-2 ethylamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5089335A true JPS5089335A (enExample) | 1975-07-17 |
| JPS5327252B2 JPS5327252B2 (enExample) | 1978-08-07 |
Family
ID=26217694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9546674A Expired JPS5327252B2 (enExample) | 1973-04-17 | 1974-08-19 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5327252B2 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
| CN103833588A (zh) * | 2012-11-16 | 2014-06-04 | 上海医药工业研究院 | 酰胺类化合物的两种晶型、制备方法及其应用 |
| US10953011B2 (en) | 2019-05-31 | 2021-03-23 | Viracta Therapeutics Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
| US12427152B2 (en) | 2016-07-15 | 2025-09-30 | Viracta Therapeutics, Inc. | HDAC inhibitors for use with NK cell based therapies |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5363723U (enExample) * | 1976-11-01 | 1978-05-29 |
-
1974
- 1974-08-19 JP JP9546674A patent/JPS5327252B2/ja not_active Expired
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
| CN103833588A (zh) * | 2012-11-16 | 2014-06-04 | 上海医药工业研究院 | 酰胺类化合物的两种晶型、制备方法及其应用 |
| US12427152B2 (en) | 2016-07-15 | 2025-09-30 | Viracta Therapeutics, Inc. | HDAC inhibitors for use with NK cell based therapies |
| US10953011B2 (en) | 2019-05-31 | 2021-03-23 | Viracta Therapeutics Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5327252B2 (enExample) | 1978-08-07 |